Frequent FDA Leadership Shakeups Put Industry at ‘Tipping Point’, Bloomberg Law

Morgan Lewis partner Maarika Kimbrell was quoted in a Bloomberg Law article about a leadership transition at FDA’s Center for Drug Evaluation and Research.

“With greater turnover in the position, incumbents will by necessity spend more time learning the ropes, so to speak, and less time fixing them,” she said.

Read the full Bloomberg Law article >>
Subscription may be required.